Annual Accounts Payable
$9.24 M
+$1.32 M+16.70%
December 31, 2023
Summary
- As of February 21, 2025, LAB annual accounts payable is $9.24 million, with the most recent change of +$1.32 million (+16.70%) on December 31, 2023.
- During the last 3 years, LAB annual accounts payable has risen by +$16.00 thousand (+0.17%).
- LAB annual accounts payable is now -12.88% below its all-time high of $10.60 million, reached on December 31, 2021.
Performance
LAB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$10.93 M
-$1.64 M-13.08%
September 30, 2024
Summary
- As of February 21, 2025, LAB quarterly accounts payable is $10.93 million, with the most recent change of -$1.64 million (-13.08%) on September 30, 2024.
- Over the past year, LAB quarterly accounts payable has stayed the same.
- LAB quarterly accounts payable is now -16.86% below its all-time high of $13.14 million, reached on March 31, 2024.
Performance
LAB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LAB Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.7% | 0.0% |
| 3 y3 years | +0.2% | +79.4% |
| 5 y5 years | +129.3% | +79.4% |
LAB Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.9% | +16.7% | -16.9% | +79.4% |
| 5 y | 5-year | -12.9% | +79.3% | -16.9% | +112.1% |
| alltime | all time | -12.9% | +677.4% | -16.9% | +505.3% |
Standard BioTools Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.93 M(-13.1%) |
| Jun 2024 | - | $12.57 M(-4.3%) |
| Mar 2024 | - | $13.14 M(+42.3%) |
| Dec 2023 | $9.24 M(+16.7%) | $9.24 M(+26.1%) |
| Sep 2023 | - | $7.33 M(+20.3%) |
| Jun 2023 | - | $6.09 M(-0.3%) |
| Mar 2023 | - | $6.11 M(-22.8%) |
| Dec 2022 | $7.91 M(-25.4%) | $7.91 M(-14.9%) |
| Sep 2022 | - | $9.30 M(+3.2%) |
| Jun 2022 | - | $9.02 M(-28.0%) |
| Mar 2022 | - | $12.52 M(+18.1%) |
| Dec 2021 | $10.60 M(+15.0%) | $10.60 M(-1.7%) |
| Sep 2021 | - | $10.79 M(-3.9%) |
| Jun 2021 | - | $11.22 M(-10.6%) |
| Mar 2021 | - | $12.55 M(+36.1%) |
| Dec 2020 | $9.22 M(+79.0%) | - |
| Dec 2020 | - | $9.22 M(-16.0%) |
| Sep 2020 | - | $10.97 M(+16.9%) |
| Jun 2020 | - | $9.38 M(-0.6%) |
| Mar 2020 | - | $9.44 M(+83.2%) |
| Dec 2019 | $5.15 M(+27.9%) | - |
| Dec 2019 | - | $5.15 M(-3.5%) |
| Sep 2019 | - | $5.34 M(-33.9%) |
| Jun 2019 | - | $8.07 M(+16.4%) |
| Mar 2019 | - | $6.94 M(+72.2%) |
| Dec 2018 | $4.03 M(-4.4%) | $4.03 M(-35.5%) |
| Sep 2018 | - | $6.25 M(-6.0%) |
| Jun 2018 | - | $6.64 M(+27.6%) |
| Mar 2018 | - | $5.21 M(+23.6%) |
| Dec 2017 | $4.21 M | $4.21 M(-10.8%) |
| Sep 2017 | - | $4.72 M(+22.4%) |
| Jun 2017 | - | $3.86 M(+3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $3.73 M(-5.9%) |
| Dec 2016 | $3.97 M(-34.9%) | $3.97 M(-18.6%) |
| Sep 2016 | - | $4.87 M(-16.4%) |
| Jun 2016 | - | $5.83 M(+31.3%) |
| Mar 2016 | - | $4.44 M(-27.2%) |
| Dec 2015 | $6.09 M(+3.0%) | $6.09 M(-3.3%) |
| Sep 2015 | - | $6.30 M(+5.7%) |
| Jun 2015 | - | $5.96 M(+8.4%) |
| Mar 2015 | - | $5.50 M(-7.0%) |
| Dec 2014 | $5.92 M(+36.0%) | $5.92 M(-18.7%) |
| Sep 2014 | - | $7.28 M(-4.7%) |
| Jun 2014 | - | $7.64 M(-4.5%) |
| Mar 2014 | - | $8.00 M(+83.8%) |
| Dec 2013 | $4.35 M(+70.4%) | $4.35 M(+27.8%) |
| Sep 2013 | - | $3.41 M(+70.6%) |
| Jun 2013 | - | $2.00 M(-37.9%) |
| Mar 2013 | - | $3.21 M(+25.8%) |
| Dec 2012 | $2.56 M(-36.3%) | $2.56 M(-23.6%) |
| Sep 2012 | - | $3.35 M(+1.5%) |
| Jun 2012 | - | $3.29 M(-19.7%) |
| Mar 2012 | - | $4.10 M(+2.3%) |
| Dec 2011 | $4.01 M(+27.1%) | $4.01 M(-14.3%) |
| Sep 2011 | - | $4.68 M(+56.9%) |
| Jun 2011 | - | $2.98 M(-36.2%) |
| Mar 2011 | - | $4.67 M(+48.1%) |
| Dec 2010 | $3.15 M(+41.9%) | $3.15 M(+74.8%) |
| Sep 2010 | - | $1.80 M(-18.8%) |
| Dec 2009 | $2.22 M(-22.2%) | $2.22 M(-22.2%) |
| Dec 2008 | $2.86 M(+5.0%) | $2.86 M(-11.5%) |
| Jun 2008 | - | $3.23 M(+18.6%) |
| Dec 2007 | $2.73 M(+129.4%) | $2.73 M |
| Dec 2006 | $1.19 M | - |
FAQ
- What is Standard BioTools annual accounts payable?
- What is the all time high annual accounts payable for Standard BioTools?
- What is Standard BioTools annual accounts payable year-on-year change?
- What is Standard BioTools quarterly accounts payable?
- What is the all time high quarterly accounts payable for Standard BioTools?
- What is Standard BioTools quarterly accounts payable year-on-year change?
What is Standard BioTools annual accounts payable?
The current annual accounts payable of LAB is $9.24 M
What is the all time high annual accounts payable for Standard BioTools?
Standard BioTools all-time high annual accounts payable is $10.60 M
What is Standard BioTools annual accounts payable year-on-year change?
Over the past year, LAB annual accounts payable has changed by +$1.32 M (+16.70%)
What is Standard BioTools quarterly accounts payable?
The current quarterly accounts payable of LAB is $10.93 M
What is the all time high quarterly accounts payable for Standard BioTools?
Standard BioTools all-time high quarterly accounts payable is $13.14 M
What is Standard BioTools quarterly accounts payable year-on-year change?
Over the past year, LAB quarterly accounts payable has changed by $0.00 (0.00%)